Literature DB >> 3011845

A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein.

M C Bohler, R A Seger, R Mouy, E Vilmer, A Fischer, C Griscelli.   

Abstract

Twenty-five patients suffering from chronic granulomatous disease (CGD) and their families were investigated. Defects in the superoxide generating system were characterized at the level of the heme-containing cytochrome b and of the FAD-containing flavoprotein, both localized in the plasma membrane of granulocytes. It was confirmed that in most of the typical cases (18 of 22), the complete inability of superoxide generation was associated with the absence of detectable cytochrome b. Mothers but not fathers of such male patients were characterized by a diminished content of cytochrome b, confirming that the affected gene is localized on the X chromosome. In contrast, the granulocytes of four other typical patients (two female and two male) contained normal amounts of cytochrome b, whereas oxidative activity was absent. Since no abnormality of oxidative activity as well as of cytochrome b was found in granulocytes of the mothers and fathers of these patients, an autosomal recessive mode of inheritance of the disease is probable. The flavoprotein deficiency found in the granulocytes of four male patients was always associated with an absence of detectable cytochrome b. This could indicate a structural relationship between flavoprotein and cytochrome b (e.g., a flavocytochrome). Three further patients with mild X-linked CGD contrasted with the patients with severe or classic X-linked disease; the oxidative activity of their phagocytes was diminished but not absent, and the cytochrome b present, albeit in small amounts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011845     DOI: 10.1007/bf00918746

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  26 in total

1.  Activity and activation of the granulocyte superoxide-generating system.

Authors:  P E Newburger; M E Chovaniec; H J Cohen
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

2.  Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease.

Authors:  R L Baehner; R B Johnston; D G Nathan
Journal:  J Reticuloendothel Soc       Date:  1972-08

3.  Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.

Authors:  G R Gray; G Stamatoyannopoulos; S C Naiman; M R Kliman; S J Klebanoff; T Austin; A Yoshida; G C Robinson
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections.

Authors:  M A Arnaout; J Pitt; H J Cohen; J Melamed; F S Rosen; H R Colten
Journal:  N Engl J Med       Date:  1982-03-25       Impact factor: 91.245

6.  Chronic granulomatous disease due to granulocytes with abnormal NADPH oxidase activity and deficient cytochrome-b.

Authors:  R A Seger; L Tiefenauer; T Matsunaga; A Wildfeuer; P E Newburger
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

7.  The association of FAD with the cytochrome b-245 of human neutrophils.

Authors:  A R Cross; O T Jones; R Garcia; A W Segal
Journal:  Biochem J       Date:  1982-12-15       Impact factor: 3.857

8.  Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions.

Authors:  A Fischer; R Seger; A Durandy; B Grospierre; J L Virelizier; F Le Deist; C Griscelli; E Fischer; M Kazatchkine; M C Bohler
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Functional relationship of the cytochrome b to the superoxide-generating oxidase of human neutrophils.

Authors:  T G Gabig; E W Schervish; J T Santinga
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

10.  Impaired granulocyte superoxide production and prolongation of the respiratory burst due to a low-affinity NADPH-dependent oxidase.

Authors:  S B Shurin; H J Cohen; J C Whitin; P E Newburger
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

View more
  13 in total

Review 1.  The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.

Authors:  A W Segal
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

2.  Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.

Authors:  T J Mühlebach; J Gabay; C F Nathan; C Erny; G Dopfer; H Schroten; V Wahn; R A Seger
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.

Authors:  J T Curnutte; R L Berkow; R L Roberts; S B Shurin; P J Scott
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 4.  New perspectives in chronic granulomatous disease.

Authors:  R A Ezekowitz; P E Newburger
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

Review 5.  Subcellular localization and dynamics of components of the respiratory burst oxidase.

Authors:  N Borregaard
Journal:  J Bioenerg Biomembr       Date:  1988-12       Impact factor: 2.945

6.  A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.

Authors:  M C Dinauer; J T Curnutte; H Rosen; S H Orkin
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.

Authors:  C Barbey; J M Tiercy; N Fairweather; H Niemann; R Seger; G Corradin
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.

Authors:  J P Hossle; M de Boer; R A Seger; D Roos
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

9.  Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease.

Authors:  T J Mühlebach; H J Feickert; K Welte; R A Seger
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

10.  Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype.

Authors:  G de Saint-Basile; M C Bohler; A Fischer; J Cartron; J L Dufier; C Griscelli; S H Orkin
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.